A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood
Clinical trial NCT05380947 · COMPLETED
Trial details
- NCT number
- NCT05380947
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2022-09-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.